![Nessim Torabi-Pour](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nessim Torabi-Pour
Directeur Technique/Scientifique/R&D chez SiSaf Ltd.
Profil
Nessim Torabi-Pour is currently the Chief Clinical Officer at SiSaf Ltd.
Previously, he worked as a Manager-Technical Project at pSiMedica Ltd.
He holds a doctorate degree from the University of London and a graduate degree from King's College London.
Postes actifs de Nessim Torabi-Pour
Sociétés | Poste | Début |
---|---|---|
SiSaf Ltd.
![]() SiSaf Ltd. BiotechnologyHealth Technology SiSaf Ltd. engages in the design and formulation of drugs for topical delivery systems. Its proprietary technology represents a highly effective, non-irritant carrier for cosmetic and medical products, where improved skin penetration, targeting, and controlled release are required. The firm uses nanosilicon as a carrier for active compounds allowing them to penetrate deep beneath the skin's epidermal barrier for controlled release. It operates through its offices located in Belfast and San Jose. The company was founded by Suzanne Roghieh Saffie-Siebert and Timothy John Brundle in 2006 and is headquartered in Belfast, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Anciens postes connus de Nessim Torabi-Pour
Sociétés | Poste | Fin |
---|---|---|
pSiMedica Ltd.
![]() pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Corporate Officer/Principal | - |
Formation de Nessim Torabi-Pour
University of London | Doctorate Degree |
King's College London | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
SiSaf Ltd.
![]() SiSaf Ltd. BiotechnologyHealth Technology SiSaf Ltd. engages in the design and formulation of drugs for topical delivery systems. Its proprietary technology represents a highly effective, non-irritant carrier for cosmetic and medical products, where improved skin penetration, targeting, and controlled release are required. The firm uses nanosilicon as a carrier for active compounds allowing them to penetrate deep beneath the skin's epidermal barrier for controlled release. It operates through its offices located in Belfast and San Jose. The company was founded by Suzanne Roghieh Saffie-Siebert and Timothy John Brundle in 2006 and is headquartered in Belfast, the United Kingdom. | Health Technology |
pSiMedica Ltd.
![]() pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Part of EyePoint Pharmaceuticals, Inc., pSiMedica Ltd. is a British company that researches and develops nanostructured porous silicon. The company is based in Malvern, UK. The company was founded by Sam di Giacomo. The CEO is Roger Aston. pSiMedica was acquired by EyePoint Pharmaceuticals, Inc. on August 05, 2004 for $40.97 million. | Commercial Services |